🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks JTH! 😉

We *tried* to do a meta-analysis on menstrual bleeding in FXI inhibitor studies - not only is it not a tracked outcome, but hardly any patients were even capable of menstruation. Read our call to action for improving capture of HMB in anticoagulant trials. authors.elsevier.com/a/1k6ci5TuFxIu…

Bethany Samuelson Bannow MD, MCR Important work highlighting a critical gap. Menstrual bleeding outcomes deserve attention in anticoagulant trials, time to prioritize inclusivity in research. 💡🩸 #ClinicalTrials

Awesome opportunity for med/pharmacy/PhD students to pursue an interesting project and get mentorship support! I love that HTRS continues to extend these important initiatives to expose students to the awesome world of hemostasis/thrombosis research! htrs.org/grants-awards/…

A behind-the-scenes look at yesterday's #ASH24 On Location interviews with Editor-in-Chief Aaron Gerds MD, MS and Deputy Editor Bethany Samuelson Bannow MD, MCR 🩸 Stay tuned for the full videos coming soon!

Super insightful and well-written piece by an IM resident I'm privileged to be working with... some heme/onc fellowships will be very lucky to get applications from her in 2025... rdcu.be/d3tfG

So honored to work with an all-star team led by the incredible Jori May on this paper discussing the role of AC stewardship... it's a whole lot more than INR monitoring! sciencedirect.com/science/articl…

At #ASH24, Bethany Samuelson Bannow MD, MCR caught up with Dr. Anne de Vaan to discuss her research on #postpartum #hemorrhage in #hemophilia A and B carriers following enhanced prophylactic clotting factor suppletion. Check out their conversation below! ow.ly/C06I50UyKYT

This was a satisfying, if depressing, editor's corner to write. I invite and encourage all researchers to consider how they can be more inclusive of participants with child-bearing potential. ashpublications.org/ashclinicalnew…

📢 Start the year right with the AC Forum's Newsletter! Our January edition is live, and it's packed with fresh resources, webinars, upcoming events, and so much more to help you achieve your professional goals in 2025! 👉 Log in to your member account now to explore it all:

When 14 journals choose to publish the same article simultaneously, you know the topic is important. This is about predatory journals, which are out to catch the inexperienced authors. If you are thinking of submitting a paper following an invitation, read this first. #publishing

For any of you #WomenInMedicine, my phenomenal coach Stephanie Byerly will be hosting a free workshop on confidence building tomorrow... you don't want to miss it! stephaniebyerly.mykajabi.com/unlock-your-un…

Heads up to patients and providers! National Bleeding Disorders Foundation has an awesome new program to provide accurate information and support to patients experiencing bleeding symptoms: betteryouknow.org/women/at-risk/…

Excited to share an important new document from Anticoagulation Forum and FWGBD addressing the care of folks with the potential to menstruate (or enter menopause!) or become pregnant. Check it out! acforum.org/web/resource_f…

BREAKING from NEJM In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is : 🔘Noninferior to full-dose (5 mg BID) for VTE recurrence 🔘Lower bleeding risk (12.1% vs. 15.6%) 🔘Safer extended anticoagulation, same protection.

Non-anemic iron deficiency (NAID) and iron deficiency anemia (IDA) affect millions of women, yet many are often underdiagnosed and undertreated. Why? Structural barriers, inconsistent diagnostic thresholds, and lack of awareness. Learn more: ow.ly/SB8L50VtWOG

💜Vasculearn Network Network is hosting a Women's Health Support Group May 12th @ 7PM EST💜 This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis 👉Register lnkd.in/esHHKW62

Super interesting findings! We've been using chromogenic FVIII for our AFAB folks with FVIII mutations for awhile - will you make the switch? jthjournal.org/article/S1538-…

💜To close out Women’s Health Week, we’re spotlighting a vital conversation for our clinician community: How do we safely manage menstruation, anticoagulation, and contraception in patients with VTE? Dr. Bethany Samuelson Bannow (Bethany Samuelson Bannow MD, MCR and Dr. Period Hackers ), a

🩸This #MenstrualHygieneDay let's advocate, educate, and empower! Join FWGBD in doing this by reading our #MHDay2025 newsletter here: conta.cc/3FuzNr6